2022 ASCO Recaps : Episode 2

Video

Dr. Luckenbaugh looks back on testicular cancer/germ cell tumor research from ASCO 2022

Author(s):

Urology Times staff

Amy N. Luckenbaugh, MD, recaps 5 presentations from the 2022 American Society of Clinical Oncology Annual Meeting.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Amy N. Luckenbaugh, MD, gives a recap of noteworthy testicular cancer/germ cell tumor abstracts presented at the 2022 American Society of Clinical Oncology Annual Meeting. Luckenbaugh is an assistant professor of urology at Vanderbilt University Medical Center, Nashville, Tennessee.

      The following 5 abstracts are summarized:

      Abstract 5007 (Truong et al): Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management

      Abstract 5008 (Tandstad et al): Late relapses in testicular cancer: Results from a national cohort

      Abstract 5032 (Taza et al): Late relapses in testicular cancer: Results from a national cohort

      Abstract 5033 (Zheng et al): Epigenetic age acceleration in U.S. testicular cancer survivors (TCS)

      Abstract 5034 (King et al): Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT)

      Related Videos
      Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
      Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
      Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
      Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
      Ruchika Talwar, MD, on how urologists can get involved in advocacy
      Ruchika Talwar, MD, on how urologists can get involved in advocacy
      Ruchika Talwar, MD, discusses ongoing drug shortages in urology
      Ruchika Talwar, MD, discusses ongoing drug shortages in urology
      William Furuyama, MD, answers a question during a Zoom video interview
      William Furuyama, MD, on community factors’ influence on urinary incontinence
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Investigators explore social vulnerability and urinary incontinence
      William Furuyama, MD, answers a question during a Zoom video interview
      William Furuyama, MD, on social vulnerability and urinary incontinence
      Brendan Frainey, MD, on microbiome composition in patients with spina bifida
      Brendan Frainey, MD, on microbiome composition in patients with spina bifida
      Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
      Household toilet and sanitation insecurity’s implications for urinary symptoms and beyond
      Elisabeth M. Sebesta, MD, answers a question during a Zoom video interview
      Dr. Sebesta on future research on interventions for toilet and sanitation insecurity
      Related Content
      Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
      May 16th 2025

      Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

      Melissa Kaufman, MD, PhD, FACS Hannah Clarke
      The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.
      Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
      April 28th 2025

      Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause

      Melissa Kaufman, MD, PhD, FACS
      In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
      Exploring the potential role of ctDNA as a biomarker in kidney cancer
      February 7th 2025

      Exploring the potential role of ctDNA as a biomarker in kidney cancer

      Alan Tan, MD
      "The take-home point from our study of these 92 patients is that in metastatic kidney cancer, there's a high concordance [between] MRD positivity and patients having progressive disease," says Alan Tan, MD.
      What does the BCG shortage look like in 2021?
      November 1st 2021

      What does the BCG shortage look like in 2021?

      Urology Times staff
      “I wouldn't be surprised if we have spotty distribution areas of concern for the next several years,” says Sam S. Chang MD, MBA, on the latest episode of the UT podcast Speaking of Urology.
      In-depth study of microbiomes may lead to better UTI care for patients with spina bifida
      January 6th 2025

      In-depth study of microbiomes may lead to better UTI care for patients with spina bifida

      Brendan T. Frainey, MD
      "The goal for this study was to understand, over the lifetime in individuals with spina bifida, what bacteria are present in their urine normally, what bacteria are present when they have a UTI, and what are some important clinical differences we can tease out to help understand which patients should really be treated," says Brendan T. Frainey, MD.
      Navigating work-life balance: VUMC’s Family Planning for Surgeons Series
      December 23rd 2024

      Navigating work-life balance: VUMC’s Family Planning for Surgeons Series

      Lauren E. Corona, MD
      "I hope that [attendees] will be exposed to a community where they feel that they're able to freely ask questions, gain accurate information, and feel heard, validated, and connected," says Lauren E. Corona, MD.
      © 2025 MJH Life Sciences

      All rights reserved.